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 ABSTRACT 
A META-ANALYSIS OF COMPONENT TREATMENT STUDIES:  
ARE THE PARTS AS GOOD AS THE WHOLE? 
by Erin Jane Clarke 
December 2011 
 Psychotherapy has been proven effective in treating a variety of mental health 
issues.  However, there is disagreement in psychotherapy research about whether or not 
factors common to all psychotherapies or specific ingredients within a treatment package 
are responsible for successful treatment outcomes.  Component studies are research 
designs specifically aimed at identifying the mechanisms of change in a full treatment 
package.  Component studies do this by comparing the differences in outcome among 
dismantled treatment components and the full treatment protocol. The present meta-
analytic review of component studies examined whether or not differences between these 
two treatment groups generally exist.  Fifty-nine component studies were analyzed to 
determine the difference in the outcome between dismantled treatments and full treatment 
packages. Studies were coded on a number of variables including sample size, 
intervention type, treatment problem, gender, and age. As hypothesized, results from 59 
comparisons of post-treatment score differences revealed that there are not differences 
between the full treatment package and the component treatment (d = -.005). These 
results mirrored the findings from Ahn and Wampold’s (2001) original meta-analysis of 
20 component studies. However, there was significant heterogeneity among these studies, 
with treatment effectiveness moderated by age (i.e., older clients benefiting more from  
 
ii 
the full treatment packages; β = -.316).  The present study also examined treatment 
outcomes at follow-up. The follow-up results from 44 comparisons of component groups 
and full treatment package groups indicated that the full treatment package was more 
effective than the component group (d = -.157).  The results from this study suggest that 
specific ingredients in psychotherapy packages do have an effect, but these effects may 
not be apparent at post treatment, and, instead, will appear in follow-up outcomes.   
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CHAPTER I 
INTRODUCTION 
 Psychotherapy has been proven effective in treating a variety of mental health 
issues.  However, it is still unclear how psychotherapy works. Component studies are 
designed to help researchers identify the active ingredients that are responsible for the 
benefits yielded by a full treatment protocol (Ahn & Wampold, 2001; Borkovec, 1990). 
A component design involves splitting the therapeutic elements comprising a treatment 
and delivering them in separate components of therapy.  This design can be delivered 
either to different groups or to the same participants in sequence to evaluate the 
effectiveness of specific active ingredients (Longmore & Worrell, 2007). The aim of this 
project is to determine whether component studies generally find differences in outcome 
among dismantled treatment components and the full treatment protocol. This issue was 
addressed in an earlier meta-analysis by Ahn and Wampold (2001), but the present study 
provides a more comprehensive, updated meta-analysis.  
 The psychotherapy research field has moved from debating whether 
psychotherapy is effective in the treatment of psychological disorders (e.g., Eysenck, 
1952) to debating how and why psychotherapy is effective.  Although, meta-analytic 
investigations (e.g., Smith & Glass, 1977; Smith, Glass, & Miller, 1980) have shown that 
most therapeutic practices are generally effective for treating a wide range of clinical 
disorders (Task Force on Evidence-Based Practice in Psychology, 2006), there is still 
disagreement among researchers about whether client improvement is due to specific 
ingredients of treatments (e.g., Eysenck, 1994; Giles, Neims, & Prial, 1993; Strupp, 
1986) or to factors common in all therapies (e.g., Ahn & Wampold, 2001; Frank & Frank, 
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1991; Garfield, 1998; Task Force on Evidence-Based Practice in Psychology, 2006; 
Wampold, 2001).  Advocates for empirically supported treatments (ESTs) believe that 
specificity (i.e., attributing to specific ingredients) is key to the therapeutic process.   The 
EST movement supports a process that begins with formulating theories to explain 
disorders, problems, or complaints; designing treatments that contain specific ingredients 
that are based on the theories formulated; and finally testing the treatments through 
randomized controlled trials (RCTs). In an RCT design, participants are randomly 
assigned either to an experimental treatment, a standard practice comparison, or a control 
condition. The control condition consists of either no treatment or a placebo treatment. At 
the end of the study, the outcomes of the experimental treatment group are compared to 
the control condition outcomes or the standard practice comparison to determine if the 
experimental treatment worked better (Sibbald & Roland, 1998).  If the treatment is 
supported through RCTs, then the benefits of psychotherapy are attributed to the specific 
ingredients that were originally posited (Castelnuovo, Faccio, Molinari, Nardon, & 
Salvini, 2004; Wampold, 2001).   
   Critics of this approach believe that common factors (i.e., healing context, 
working alliance, belief in rationale for treatment and in treatment itself) are responsible 
for treatment benefits.  Advocates of the common factor approach emphasize the 
commonalities among therapies. Wampold (2001) wrote: 
 All therapies involve the relationship of a client and therapist, each of whom 
 believes in the efficacy of the treatment.  The therapist provides the client with a 
 rationale for the disorder and administers a procedure that is consistent with 
 that rationale.  The client discusses the most intimate details of his or her life, 
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 confident that the therapeutic relationship will continue.  The particular specific 
 ingredients contained in the treatment, according to the contextual model, are not 
 responsible for therapeutic benefits. (p. xii) 
Critics of the specific ingredients approach, often point to the “Dodo Bird Verdict” to 
support their claims that common factors are the causal proponents of change in 
psychotherapy.  The “Dodo Bird Verdict” derived from Rosenzweig’s (1936) seminal 
survey when he concluded that there were “some implicit common factors in diverse 
methods of psychotherapy” that were so pervasive that the differences between types of 
therapy treatment would be very small (p. 412).  He summarized this assertion by quoting 
Alice in Wonderland, “everybody has won, so all shall have prizes,” which was the Dodo 
bird’s verdict after judging the race (Luborsky et al., 2002, p. 1).  Rosenzweig’s theory 
that common factors are the key to psychotherapy success has gained support from meta-
analyses of comparative studies (Luborsky et al., 2002; Luborsky & Singer, 1975; 
Wampold et al., 1997) in which one type of psychotherapy is compared to a different 
type of psychotherapy to see which one is more effective in treating clients. For example, 
a comparative study could compare cognitive behavioral therapy to interpersonal therapy 
for the treatment of depression. In general, these meta-analyses found that although 
psychotherapy was more effective than no therapy, the type of psychotherapy did not 
make a significant difference on treatment outcome measures.   
 In 1995, the APA Division 12 (Clinical Psychology) Task Force on Promotion 
and Dissemination of Psychological Procedures published criteria for identifying 
empirically validated treatments (eventually renamed empirically supported treatments) 
for particular disorders (Evidence-Based Practice in Psychology, 2006).  The Division 12 
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Task Force described this publication as an effort to promote treatments delivered by 
psychologists, because there was a perception in the health field that psychological 
treatments were ineffective or inferior to pharmacological treatment (Evidence-Based 
Practice in Psychology, 2006).   The criteria used by the Division 12 Task Force sparked 
controversy after they published a report identifying 18 treatments whose empirical 
support they considered to be well established.  The criteria for being a well-established 
treatment included a treatment having been tested in RCTs with a specific population and 
implemented using a treatment manual (Evidence-Based Practice in Psychology, 2006).  
 Some psychologists argued that conducting research using RCTs and trying to 
identify specific active ingredients may harm research and the practice of psychotherapy 
because it underemphasizes the common variables that may be the agents for 
effectiveness in therapy.  Garfield (1998) argued that although we should conduct 
research and the efforts of the Division 12 Task Force should be applauded, the scientific 
method being used is biased toward manualized treatments that dominate the field. 
Garfield (1998) went on to say that this approach is an “attempt to certify and mandate 
the use of such therapies prematurely… and by emphasizing the name or form of 
psychotherapy, essentially to minimize the importance of patient variability and therapist 
skill” (p. 121). 
 Although advocates of both sides want to learn about the active ingredients that 
lead to positive change in the therapeutic process, the proponents of specific factors 
believe that these specific factors or techniques may be responsible for the therapeutic 
successes of psychotherapy.  It is understandable why some psychologists and 
researchers would not like the view that common factors and not specific factors are 
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responsible for psychotherapy success.  As stated by Frank (1971), “ little glory derives 
from showing that the particular method which one has mastered with so much effort 
may be indistinguishable from other methods in its effects” (p. 350).   
 Understanding the active ingredients in psychotherapy appears to be a goal that 
all psychotherapy researchers value. Component studies have become the gold standard 
for trying to accomplish this goal (Ahn & Wampold, 2001).  The present meta-analysis of 
component studies examined whether differences are generally found between 
dismantled components and the full treatment protocol.  If the meta-analysis were to 
reveal that there are no differences between components and the full treatment protocol, 
then there may be theoretical implications to consider.  Specifically, results that show that 
there are no differences between components and the full treatment protocol may provide 
evidence in favor of common factors being responsible for change more than specific 
factors.  Also, such findings may suggest that the research design currently utilized in 
most component studies is not as useful as believed. 
History of Component Designs 
 
 Psychotherapy research is conducted using several research designs that have 
evolved over time. Psychotherapy designs have included comparing treatment to no-
treatment conditions, comparing treatment conditions to placebo conditions, or 
comparing treatment conditions to alternative treatments.   Establishing specific causal 
factors has been a struggle because, although most psychotherapy designs can draw a 
cause-and-effect conclusion, it remains unclear what specific causal factors within the 
therapy are responsible for the change (Borkovec & Castonguay, 1998).  
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 In the 1960s, systematic desensitization became a widely accepted treatment for a 
variety of anxiety disorders.  Even though there was a large amount of empirical support 
behind the use of systematic desensitization, it was unclear which of the different 
variables composing the treatment was causing the behavioral change.  The developer of 
systematic desensitization, Wolpe, theorized that the change in behavior was due to an 
underlying neural process called “counter-conditioning” or “reciprocal inhibition” that 
required all components of the treatment to be effective (Davison, 1968, p. 92).  The 
research supporting systematic desensitization used comparative designs comparing 
systematic desensitization to alternative therapy, placebo therapy, or no treatment.   
Although there was support that the treatment worked better than no treatment/placebo or 
alternate conditions, there was not clear evidence that counter-conditioning was the 
process causing change.  In a review of laboratory studies, Lang (1969) suggested a 
method for analyzing desensitization.  He wrote:  
Perhaps the most prevalent approach involves a sequential dismantling of the 
basic treatment unit. This approach is rather like that of a curious aborigine who 
hopes to understand a modern automobile. Clinical reports tell him that it runs.  
He has even taken it out for a spin.  But he does not understand what makes it go. 
His plan is to start pulling things off it (perhaps starting with the shiny hood 
ornament) until it stops, hoping that he will come to know what parts are critical 
to its functioning- and that the owner will not mind too much the mess he has 
made of things. (pp. 161-162)  
  Davison (1968) was the first to test Wolpe’s theory of how systematic 
desensitization worked using a dismantling approach. Davison asserted that until tested it 
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was possible that the favorable outcomes could be due to relaxation alone, to the gradual 
exposure to aversive stimuli, or to nonspecific relationship factors. He developed the first 
component study by “dismantling” systematic desensitization into different treatment 
groups composed of the different components of therapy and comparing them.  Davison 
recruited 28 female volunteers from a junior college who reported being very afraid of 
nonpoisonous snakes.  The study divided the women into four treatment groups.  The first 
group received the whole desensitization package. The second group called pseudo-
desensitization received relaxation but no exposure.  The third group received an 
exposure treatment without relaxation, and the fourth group was not given any treatment. 
Davison found a significant difference between the groups that received the full treatment 
package and the groups that only received part of the package.  The finding that the full 
treatment package worked better than any of the parts alone provided evidence for 
Wolpe’s theory of counter-conditioning.  Follow-up studies (e.g., Miller & Nawas, 1970; 
Nawas, Welsh, & Fishman, 1970) used the same dismantling design as Davison’s (1968) 
study and provided evidence that relaxation was not an important component to 
systematic desensitization in the treatment of snake phobia.  Furthermore, in 1975, Marks 
reviewed all of the empirical literature and concluded that it was the graded exposure in 
systematic desensitization that was the key element in treating phobias (as cited in Tryon, 
2005). 
 This new dismantling design, termed a component study, provided a way to test 
theory and provide evidence for active ingredients in treatment packages. Component 
studies can be conducted by using either a dismantling design or an additive design (e.g., 
Ahn & Wampold, 2001; Borkovec, 1990; Borkovec & Miranda, 1999).  As demonstrated 
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by the Davison (1968) study, dismantling studies are designed to help researchers 
identify the active ingredients that are responsible for the benefits yielded by a full 
treatment protocol (e.g., Ahn & Wampold, 2001; Borkovec & Miranda, 1999). A 
dismantling design involves splitting the therapeutic elements comprising a treatment and 
delivering them in separate components of therapy. If the treatment component without 
the “specific active ingredient” results in a less successful outcome than the complete 
treatment package, then the researcher can conclude that there is evidence that the active 
ingredient is key to the effectiveness of the treatment (e.g., Ahn & Wampold, 2001; 
Borkovec & Castonguay, 1998; Borkovec & Miranda, 1999).  Additive designs add a 
specific ingredient to a treatment to see if this ingredient increases the effectiveness of a 
particular treatment.  The idea behind the additive design is that each component in 
psychotherapy is “partially effective” so that the combination of these partially effective 
components will lead to a more powerful treatment than any component alone (e.g., Ahn 
& Wampold, 2001; Borkovec, 1990; Borkovec & Miranda, 1999). 
 Through these two types of designs, component studies can provide evidence of 
specificity. In an additive design, evidence of specificity is provided when the added 
component increases the overall effectiveness of the full treatment package.  In a 
dismantling design, evidence of specificity is provided when dismantling one component 
reduces the effectiveness of the full treatment. Advocates of these designs argue that 
component designs are superior to designs in which two treatment packages are 
compared, because they provide specific conclusions about causal factors, and they 
provide greater control over many extraneous variables that hinder and confound 
interpretations of outcome (Borkovec & Miranda, 1999).  Comparative designs can 
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provide evidence that a particular therapy caused a degree of change beyond the amount 
of change caused by factors common to all therapy and beyond the alternative therapy 
(Borkovec & Castonguay, 1998).  
 In addition to component studies being used to provide evidence for active 
ingredients, they also have been used to debunk certain components of a treatment. Most 
notably, component studies have been used to examine the eye movement component 
within Eye Movement Desensitization and Reprocessing (EMDR) therapy.  Because 
many mainstream psychotherapy researchers have suspected that the eye movement 
component of EMDR is grounded in pseudo-science (e.g., Herbert, 2000), several 
component studies have been conducted to demonstrate that the eye movement 
component is not an active ingredient in treatment. 
  Controversy over the interpretation of component studies began after Jacobson et 
al. (1996) used a dismantling design to examine the active ingredients of cognitive-
behavioral treatment for depression.  Cognitive-behavioral therapy includes several 
interventions that address observable behavior, dysfunctional automatic thoughts, and 
inferred underlying cognitive structures or schemas.  Cognitive-behavioral therapy is 
given in a sequence that starts with changing overt behavior (i.e., behavioral activation), 
then moves to teaching the client to assess and correct situation-specific distortions in 
thinking (i.e., modification of automatic thoughts), and finally teaching the client to 
identify and modify negative core beliefs (i.e., schema therapy; Jacobson et al., 1996).  
Jacobson and colleagues (1996) randomly assigned 150 outpatients with major 
depression to groups of Behavioral Activation (BA) alone, Behavioral Activation plus 
modification of automatic thoughts (AT), or the full Cognitive Therapy (CT) package. 
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Jacobson et al. (1996) found no differences between the treatment groups. They 
interpreted this finding as evidence that BA is the essential effective ingredient of CT. 
  Rehm (2009) disagreed with this logic, asserting that dismantling studies generally 
do not find differences between the dismantled components and the full treatment. Rehm 
(2009) suggested that the lack of differences could be due to methodological problems 
with the dismantling design. Specifically, Rehm (2009) suggested two possible reasons 
for the lack of differences.  First, given that most studies have multiple, complex 
components, it is possible that clients may respond to the same component in different 
ways or may respond to different components in the same way.  Second, Rehm stated that 
it might be difficult to find differences in components if they are presented sequentially.  
For example, Rabin, Kaslow, and Rehm (1984) compared three versions of self-control 
therapy for depression on 104 women who met criteria for a major affective disorder.  
The researchers examined the patterns of change for 13 symptoms of depression. They 
found that most symptoms diminished in the first 3 to 4 weeks of therapy, and several 
symptoms (e.g., sadness and suicidal ideation) showed major reductions prior to the first 
session.  Rabin et al. (1984) found that components presented at the beginning of therapy 
led to greater reduction in symptoms of depression than those presented later in therapy. 
If components presented earlier in therapy contribute more to treatment outcome than 
those presented later, then components presented earlier may be deemed the active 
ingredient due to order effects rather than superiority over other components.  In contrast, 
if the study is one of a direct comparison, results may be more likely to indicate that both 
treatments were effective.  If component studies consistently fail to reject the null 
hypothesis (i.e., fail to find significant differences between treatment conditions), then 
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the use of component studies in general needs to be questioned as a method of evaluating 
treatment components. Further, conclusions by researchers about treatment components 
based on component studies showing no treatment differences would also need to be 
made with extreme caution.  
Component Studies Reviews 
 To date, only one meta-analytic study (Ahn & Wampold, 2001) has examined 
differences between treatment components and the full protocol in dismantling and 
additive studies. Ahn and Wampold (2001) conducted a meta-analysis on 20 components 
studies published in Behaviour Research and Therapy, Behavior Therapy, Journal of 
Consulting and Clinical Psychology, and Journal of Counseling Psychology from the 
years of 1990 to 1999. Ahn and Wampold (2001) used these four journals after they 
referenced a meta-analysis of comparative studies conducted by Shapiro and Shapiro 
(1982) and found that most outcome research came from these journals. The researchers 
concluded that including all component studies published in these four journals would be 
a comprehensive search of the literature. After coding the various component studies, 
Ahn and Wampold (2001) used an aggregate of the effect sizes of 27 comparisons by 
weighting each study’s estimate of the effect size by the inverse of the variance to yield 
the aggregate effect size estimate. Ahn and Wampold’s 27 comparisons came from 20 
studies; therefore, in some cases the same full treatment was compared to more than one 
dismantled treatment.  This method violates the independence assumption. For example 
in the Jacobson et al. (1996) study, the full treatment package (Behavioral Activation and 
Automatic Thoughts) was compared to two different component treatments (Behavioral 
Activation or Automatic Thoughts).  Instead of considering the Jacobson et al. study as 
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one study and averaging the Cohen’s ds from each component, Ahn and Wampold 
considered each comparison as an independent study, despite the fact that the full 
treatment package in each comparison was the same group of participants.  Using this 
aggregation strategy, Ahn and Wampold (2001) failed to find significant differences 
between treatment components and the full protocol (i.e., d+ estimate of -0.20). Ahn and 
Wampold also failed to find evidence of heterogeneity among the effect sizes.  This 
finding of homogeneity suggests that there were no important variables moderating the 
effect sizes.  Ahn and Wampold (2001) concluded from this finding, “the benefits of 
treatments are probably due to the pathways common to all bona fide psychological 
treatments” (p. 255).    
 Longmore and Worrell (2007) conducted a literature review of 13 component 
analysis studies that examined cognitive behavior therapy (CBT).  Specifically, they were 
interested in whether specific cognitive interventions increased the effectiveness of 
therapy. In their review, Longmore and Worrell found little evidence to support the idea 
that specific cognitive interventions significantly increase the effectiveness of therapy. In 
fact, “the review showed that, almost without exception, component studies found no 
difference in effectiveness between the cognitive and behavioral elements of CBT” (p. 
184).  Consistent with Ahn and Wampold’s (2001) position, Longmore and Worrell 
(2007) suggested that common, nonspecific therapy factors, rather than the active 
ingredients, may be responsible for why results generally show little or no differences 
between conditions in treatment component studies. The Jacobson et al. (1996) study was 
the only study included in both Ahn and Wampold’s (2001) meta-analysis and Longmore 
and Worrell’s (2007) review of component studies, which means that there are at least 12 
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relevant component studies just on CBT that were not included in the Ahn and Wampold 
meta-analysis. A review of the EMDR literature by Herbert et al. (2000) provided a list of 
12 EMDR component studies.  Only one of these studies was included in Ahn and 
Wampold’s meta-analysis, which means there are at least 11 relevant EMDR component 
studies that were not included in Ahn and Wampold’s original analysis. The purpose of 
most of these component studies was to prove that eye movement is not an active 
ingredient in EMDR.  Therefore, the inclusion of these additional EMDR studies could 
dilute findings and, although the EMDR component studies should be included, they also 
should be coded for analysis as a possible moderator.   
Present Study 
 
 Given the presumption that component studies are a gold standard of 
experimental design in psychotherapy research (e.g., Ahn & Wampold, 2001; Wampold, 
2001), it is important to examine the validity of this belief empirically. Component study 
designs may not provide researchers with as much information as generally thought.  As 
mentioned earlier, Ahn and Wampold (2001) are the only researchers who have 
conducted a meta-analysis of this topic, and they failed to find significant differences 
between treatment components and the full protocol.  Although the findings were 
noteworthy, the research literature has expanded in the past 10 years. Thus, the present 
review is an appropriate update and extension of the work by Ahn and Wampold (2001).  
The primary aim of this project was to determine whether component studies generally 
find differences in outcome among dismantled treatment components and the full 
treatment protocol. Given that the previous meta-analysis failed to find significant 
differences between the components and the full treatment package and that 
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psychotherapy research in general has failed to find significant differences between 
psychotherapies, it was hypothesized that there would be very small differences between 
treatment components and the full treatment protocol.  The present study provides a more 
comprehensive, updated meta-analysis since the last study conducted by Ahn and 
Wampold (2001). They used 20 studies from four journals (Behavioral Research and 
Therapy, Behavior Therapy, Journal of Consulting and Counseling Psychology, and 
Journal of Counseling Psychology) published between 1990 and 1999. The present study 
included studies from a wider range of sources and included literature that has been 
published since the meta-analysis by Ahn and Wampold (2001). In summary, the present 
study evaluated the following hypotheses: 
 1. There are generally no differences between the outcomes in treatment studies 
 comparing a dismantled component to the full treatment package as indicated by 
 an effect size near zero. 
 2. Results from the studies will be homogeneous. 
 3. If heterogeneity is found it may be moderated by treatment type, specifically 
 EMDR versus non-EMDR.  
In addition, a planned exploratory analysis was conducted to determine if a 
difference in effect sizes for follow-up outcome data was found between treatment 
studies comparing a dismantled component to the full treatment package.  Because this 
was an exploratory analysis, no a priori hypothesis was made. 
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CHAPTER II 
METHOD 
Compilation of Studies 
 There were no original participants in this study, as it is a meta-analysis of existing 
literature. All the studies included in the Ahn and Wampold’s (2001) meta-analysis were 
included in the present study. Furthermore, the four journals identified in their meta-
analysis were searched by hand, via a review of each table of contents, for any relevant 
articles published between the end of their review (1999) and 2010. Ten out of twelve 
studies from Longmore and Worrell’s (2007) literature review on component studies also 
were included in the present meta-analysis.  One study was excluded because it provided 
two-year follow-up data of a study already included in this study and the other study 
examine did not use a component design to examine the active ingredients. Because a 
number of studies have examined whether eye movement is an essential component of 
Eye Movement Desensitization and Reprocessing (EMDR), component studies that met 
criteria from the Herbert et al. (2000) literature review of EMDR were also included in 
the meta-analysis.  Finally, a search for relevant literature was conducted with 
PsychINFO and Medline. The search terms originally planned in the proposal had to be 
adjusted and limited due to very large search returns.  Therefore, the combination of the 
search terms “dismantling” and “treatment” was used. These combined searches yielded 
142 possible references. Any studies that met inclusion criteria and were not already 
captured by the journal searches were included in the meta-analysis.  
 The study used the same criteria for identifying relevant component studies as 
Ahn and Wampold’s (2001) study (see Appendix A for details). In addition to the study 
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criteria listed by Ahn and Wampold in Appendix A, studies must have been written in 
English, produced codable data, and included a measure of treatment effect for each 
component in the dismantling studies. Single case designs were excluded. Studies were 
not excluded if they did not specify a Master’s level therapist (as referenced in Appendix 
A); rather, studies were included as long as the therapy was provided by a graduate level 
student or a therapist supervised by a professional in the field.  
 Fifty-eight studies met the inclusion criteria and were used in the meta-analysis.  
One of the articles (Nicholas et al., 1991) counted as two studies because it reported two 
different component studies within the one article. This one article by Nicholas et al. 
(1991) had two different full treatment packages that were compared to two different 
dismantled components.  Thus the meta-analysis included 59 studies that included 3,213 
children, adolescents, and adults.  All studies included in the meta-analysis are listed in 
Table 1.  
Procedure 
 Once included, the studies were coded on a variety of dimensions including 
sample size, study design, sample type, method of measuring outcome, problem type 
(e.g., depression, anxiety), intervention type (e.g., cognitive-behavioral therapy, 
interpersonal therapy), components, client age, client gender, location of therapy (i.e., 
inpatient, outpatient), and year of publication (see Appendix B).  
 For each DV, a sample effect size was obtained by calculating the difference in the 
means of the two conditions and dividing by the pooled standard deviation (more-
component-group M- fewer-component-group M)/SD.  Typically, higher scores on 
outcome measures (dependent variables; DVs) indicate greater distress or pathology; 
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however, on occasion a higher score would indicate something positive (e.g., self-
esteem).  In these cases, the scoring was reversed so that a higher score represented 
greater impairment (e.g., lower self-esteem) to maintain consistent direction of change 
across studies. Therefore, a negative effect size indicates that the full treatment was 
superior to the dismantled treatment. If a study provided more than one DV, the DVs 
were averaged, and the average was used instead of multiple DVs. If, however, a study 
provided some DVs specific to the problem and some DVs that were more general, only 
the DVs that were specific to the problem being treated were included in the average. In 
the situation in which a study only reported the composite results from several outcome 
measures, the composite was the value included in the meta-analysis. Effect sizes were 
weighted by the inverse variance so that studies with larger samples had greater weight. 
To determine whether effect sizes were from a single population, a Q test of homogeneity 
was calculated. If Q was statistically significant, the homogeneity hypothesis would be 
rejected. In addition to the Q test of homogeneity, I2 (Higgons, Thompson, Deeks, & 
Altman, 2003) was calculated.  I2 describes the amount of variance attributable to 
heterogeneity across the studies. An I2 value of 0 would indicate absolute homogeneity 
among the studies, whereas 100 would indicate complete heterogeneity. When the effect 
sizes were found to be heterogeneous, potential moderators—including client type, type 
of intervention (specifically whether the treatment was an EMDR dismantling study), 
gender, year of publication, and age—were examined. Hedges’ (1982) meta-analytic 
equivalent to a one-way ANOVA was used to examine categorical moderators (e.g., 
client type), and Hedges and Olkin’s (1985) meta-analytic equivalent to multiple 
regression was used to examine continuous moderators (e.g., age). 
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 The choice of which type of model to use in a meta-analysis depends on the 
inferences the researcher wants to make.  If the researcher wants to make inferences only 
about the studies included, a fixed effects model would be appropriate. However, the 
present meta-analysis aimed to infer beyond the included studies and generalize to the 
population of component studies. Therefore, a random effects model was the most 
appropriate choice (Field, 2003). That is, random effects models assume that the studies 
included in the meta-analysis do not constitute all the studies that could exist (Field, 
2003).  Additionally, a random effects model allows for sampling errors by including 
both between-study and within-study variance in the error term.  In contrast, a fixed 
effects model includes within-study variance and “assume all other ‘unknowns’ in the 
model are constant” (Field, 2003, p. 107).  All analyses were conducted using Lipsey and 
Wilson’s (2001) SPSS statistical programs. 
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CHAPTER III 
RESULTS 
Is the Full Treatment Superior to the Dismantled Treatment at Completion? 
 The first hypothesis posited that dismantled components would not differ from the 
full treatment package in treatment outcomes. This hypothesis was confirmed. In studies 
where different components were removed and each variation was compared to the full 
treatment, the effect sizes were calculated for each variation compared to the full package 
and then averaged together to obtain the study’s average component d, so that each study 
yielded a single d.  This strategy was used to avoid violating the assumption of 
independence.  The average d across all 59 studies was -.005, which was trivial and not 
statistically significant (95% CI = -.09 - .08; Z = -.102, p = .91).   
 The second hypothesis (i.e., that there would be no heterogeneity among the 
studies) was not supported. Indeed, there was considerable heterogeneity among these 
studies, Q (58) = 77.4717, p = .045, I2 = 25.1, suggesting that they do not all derive from 
the same population. Because of the significant heterogeneity across the studies, further 
analyses examined potential moderators that may explain some of the variability.  
  The analyses were also conducted using the same method that Ahn and Wampold 
(2001) used in their meta-analysis.  Ahn and Wampold did not average component 
comparisons within a treatment study (for an average d) and instead treated each 
component comparison variation as a different study outcome, violating the assumption 
of independence.  There were 76 comparisons within the 59 studies. An analysis using 
Ahn and Wampold’s method of calculating d did not change the results. Specifically, the 
average d across all 76 comparisons was -.025, which also was trivial and not statistically 
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significant (95% CI = -.11 - .06; Z = -.566, p = .574). Consistent with the previous 
analysis, there was considerable heterogeneity among these studies, Q (75) = 111.6903, p 
= .0039, I2 = 32.85, suggesting that the studies do not all derive from the same 
population. 
 A final effect size was computed by selecting the d that most favored the full 
treatment against whichever variation had the poorest outcome.  Although this approach 
risked overstating the superiority of the full treatment, by possibly capitalizing on chance, 
it was the most rigorous test of the first hypothesis (i.e., that there would be no difference 
between the full treatment and a dismantled treatment).   The averaged d across the 59 
studies was -.039, which was still trivial and not statistically significant (95% CI = -.13 - 
.06; Z = -.802, p = .423). Again, there was considerable heterogeneity among these 
studies, Q (58) = 84.3616, p = .0135, I2 = 31.24, suggesting that they do not all derive 
from the same population.  Overall, across all analyses, there was no evidence that the 
full treatment was superior to a dismantled treatment at treatment completion. 
Can the Variations across Study Outcomes be Explained? 
 Several demographic variables were explored as potential moderators. The analyses 
of moderators were conducted using the data from the first method of analyses (i.e., the 
ds were calculated for each variation compared to the full package and then averaged 
together to obtain the study’s average component d, so that each study yielded a single d).  
The role of client type (whether the participant was a client or a volunteer), gender, and 
age were all assessed as potential moderators.  Client type (k = 59) did not account for the 
variability across studies, QB (1) = .236, p = .628; QW (57) = 63.465, p = .259.  The 
percent of male participants (k = 57) was assessed as a potential moderator, but gender 
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did not moderate the difference between the full treatment package and the component 
packages (β = .038; B = .001 [SE = .0016]; Z = .291, p = .771). When average age of the 
sample (k = 50) was treated as a continuous moderator, the meta-analytic analogue to a 
regression yielded a significant effect for age (β = -.319; B = -.008 [SE = .0034]; Z = -
2.419, p = .016):  The full treatment was more likely to yield superior outcomes in those 
studies in which the clients were older.    
 Because age was found to significantly moderate the outcome differences between 
the component group and the full treatment package at the end of the treatment, a scatter 
plot graph was used to visually assess for any outliers that may have influenced these 
findings.  One possible outlier (Nezu & Perri, 1989) was identified: This study’s z-score 
was the only z-score that was more than three standard deviations from the mean. 
Therefore, an additional analysis was conducted excluding this study.  Even when the 
outlier was excluded from the analysis, the regression remained significant, (β = -.296; B 
= -.007 [SE = .0034]; Z = -2.042, p = .0411).  Since age was not found as a moderator in 
the original study by Ahn and Wampold (2001), an independent sample’s t-test was used 
to compare average age in the two meta-analyses. The studies from the Ahn and 
Wampold meta-analysis had a mean of 34.92 (SD = 11.46) while the studies added for 
the current meta-analysis had a mean of 33.73 (SD = 9.76). No significant differences 
were found between the Ahn and Wampold (2001) meta-analysis (t = .393, p = .696) and 
the current meta-analysis for the average ages of clients participating in the studies 
included.     
 Year of study publication (k = 59) was examined as a possible moderator. The 
studies included in the meta-analysis were published between 1989 and 2010.  The year 
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of publication was not a significant moderator, (β = .0058; B = .0003 [SE = .007]; Z = 
.046, p = .96).  
 As mentioned earlier, there was a concern that the EMDR debunking studies may 
have diluted any full treatment package superiority by washing out differences between 
full treatment packages and component treatments.  In order to assess whether EMDR 
studies could have moderated treatment outcomes, the studies were coded categorically 
for treatment type.  Specifically, studies were assigned a number to categorize them as an 
EMDR treatment study versus a non-EMDR treatment study. Treatment type did not 
moderate the results, QB(1) = .088, p = .767; QW(57) = 62.26, p = .295.  Both the EMDR 
studies’ findings, d (10) = .0308 (95% CI = -.21 - .27; Z = .257, p = .80) and the non-
EMDR studies’ findings d (49) = -.0080 (95% CI = -.10 - .09; Z = -.17, p = .87), 
indicated no difference between the full treatment package and the component package. 
Is the Full Treatment Superior to the Dismantled Treatment at Follow-Up? 
 Forty-four of the studies that reported comparisons between components and the 
full treatment package also provided appropriate follow-up data.  Therefore, although no 
a priori hypothesis was made, potential differences between components and the full 
treatment package at follow-up were explored. If a study reported several follow-up data 
points, the follow-up point closest to six months was used to compute the effect size.  The 
average d across all 44 comparisons at follow-up was -.159, (95% CI = -.26 - .06; Z = -
3.01, p = .003).  Although -.159 is generally considered a small effect (Cohen, 1988), it 
was significant. Despite the findings that there were no differences at treatment 
completion, this significant effect suggests the clients who received the full treatment 
package did better at follow-up than the clients in the component groups.  These studies 
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were not heterogeneous [Q (43) = 46.7187, p = .322, I2 = 7.9%], suggesting that they 
were drawn from the same population. Therefore, no moderator analyses were conducted 
on the follow-up studies.  
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CHAPTER IV 
DISCUSSION 
Overall Findings of Present Meta-Analysis 
 From these results, it can be concluded that initially treatment dismantled 
components do not differ in effectiveness from the full treatment package. Individuals 
who were treated with a component treatment ingredient did not differ from individuals 
treated with the full treatment package at the end of treatment. These results supported 
the original hypothesis that there would be very small differences between the dismantled 
component and the full treatment package. The finding that there was considerable 
heterogeneity among the studies was not predicted and suggests that there may be 
moderating variables that explain why the studies yielded different outcomes.  In the 
present analysis, age was identified as a moderator:  The full treatment was more 
effective than the dismantled treatment in those studies that had older participants.  In 
addition to the original hypotheses that were proposed, an exploratory analysis yielded an 
unexpected finding that full treatment packages had better outcomes than the dismantled 
treatment components at the follow-up assessments.  It can be concluded from the follow-
up data that, in general, full treatment packages have better outcomes than component 
treatment groups over time.   
Comparison With Previous Literature 
 Although the present meta-analysis replicates some of the findings of Ahn and 
Wampold (2001), the study on which it was based, it is important to note that some 
inconsistencies were also found (e.g., homogeneity versus heterogeneity). Likewise, the 
present study examined some questions that were not addressed by Ahn and Wampold 
   
25 
(e.g., moderators, follow-up outcomes). Primarily, the finding that there were no 
differences between the full treatment package and the component treatment at 
termination was consistent with the Ahn and Wampold’s (2001) meta-analysis.  In Ahn 
and Wampold’s meta-analysis, they concluded that a lack of differences between 
component treatments and full treatments was due to nonspecific treatment factors.  Ahn 
and Wampold argued that the nonspecific factors in therapy are the casual ingredients for 
treatment gains. They contended that because nonspecific factors are present in both the 
full and component treatments, differences between these two groups would not exist.   
The present study’s null findings when comparing components and full treatments lend 
support to the idea that nonspecific factors may be responsible for the progress seen at 
treatment termination. However, as discussed in more detail below, the present study 
examined potential differences in follow-up outcomes—something that was not evaluated 
by Ahn and Wampold—and found that specific factors in the full treatment package are 
more effective over time.   
 The finding in the present meta-analysis that the studies were heterogeneous and 
moderated by age was inconsistent with Ahn and Wampold’s findings, which found 
homogeneity among the studies. It is important to note that, although the present meta-
analysis included a relatively small number of studies (k =59), it did include more studies 
than the Ahn and Wampold (2001) meta-analysis (k = 20). Therefore, the larger sample 
should have more accurately reflected the literature and increased the likelihood that the 
studies came from diverse populations, which could explain why the present study found 
heterogeneity.   
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 Because heterogeneity was found in the present study, several potential moderators 
were examined. However, only age emerged as a moderator. The finding that older 
individuals may benefit more from broader treatments is not a new finding in the research 
literature. It is important to note that the “older” group in this sample is referring to 
clients in the middle to late-middle age group.  The “older” group of individuals would be 
in their late 50s.  Kennedy and Tanenbaum (2000) reported that although older adults 
benefit from many of the standard procedures in therapy, they also have additional needs 
and could benefit from more individualized modifications in therapy to address a variety 
of areas that are new challenges for them (i.e., family functioning, social functioning, 
self-reliance). Additional needs for older individuals may explain why a less complete or 
component therapy (e.g., Behavioral Activation) may not be as beneficial to them as the 
full treatment package (e.g., Cognitive-Behavioral Therapy) in addressing more specific 
individual needs and challenges at a later stage in life. It is also possible that the clients 
that come to therapy later in life have more ingrained schemas or core beliefs. For these 
clients, the more single-faceted treatments may not address problems that a client has 
struggled with for years. A more complete treatment package may offer more tools in 
these multiple areas of need.   
 The present meta-analysis built upon the Ahn and Wampold (2001) study by 
exploring differences at follow-up outcomes. Results from the follow-up data indicated a 
small but significant effect in favor of the full treatment package. Because the effect size 
was small (d = -.159), the magnitude should be addressed when drawing conclusions 
about how much of a difference this effect is in terms of treatment. First, the typical effect 
sizes in the meta-analyses literature should be considered for the different treatment 
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outcome designs.  Lambert and Bergin (1994) reported a summary effect size of .48 when 
comparing an active psychotherapy to a placebo group (inactive treatment). Effect size 
differences drop (typically ranging from just above .00 to less than .21) when the 
treatment design is comparing two active treatments (Wampold et al., 1997).  Therefore, 
an even larger drop in effect size should be expected for the present study, which 
compares an active treatment to a variation of that same treatment minus one component. 
It is not surprising, then, that the significant effect size found for follow-up outcomes was 
small in magnitude. 
  In further evaluating what this small effect size means, it is helpful to compare it to 
other effect sizes in the psychological and medical outcome literature.  A comment by 
Rosenthal (1990) provides insight on what small effect sizes may mean by providing 
several examples of medical research and psychological research (e.g., Barnes, 1986; 
Canadian Multicentre Transplant Study Group, 1983; Centers for Disease Control 
Vietnam Experience Study, 1988; Smith & Glass, 1977; Steering Committee of the 
Physicians Health Study Research Group, 1988) where studies were ended prematurely 
due to small effect sizes in favor of the experimental treatment because it would be 
unethical to continue providing a placebo to subjects. Although the effect sizes were very 
small statistically, the effects were clinically meaningful when considering the number of 
people benefiting from treatment compared to the placebo.  For example, although r = .10 
is typically considered a small effect size, a study examining the effect of aspirin on heart 
attacks ended early when an effect size of r = .034 was found because of the large 
numbers of heart attacks prevented by taking aspirin. That is, only 104 people in the 
aspirin group experienced a heart attack compared to 189 people in the placebo group.  
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So, although the effect size of the present study is very small, it is nevertheless 
statistically significant and may be quite clinically meaningful. 
 The unexpected finding that full treatment packages are better than component 
treatments at follow-up may offer a more complete picture of why and how the 
psychotherapy process works.  The finding that there are no differences between 
treatment components and the full treatment package at the end of therapy seems to lend 
support to the argument against the specificity theory. However, the follow-up outcomes 
provide evidence in favor of the full treatment package. The idea that nonspecific factors 
alone cause therapeutic change must be challenged with the finding of better full 
treatment outcomes at follow-up. One explanation for better full treatment outcomes at 
follow-up considers time of measurement as a key factor in outcome results.  It is 
possible that differences between full treatments and components will have a delayed 
effect on treatment outcomes.  The positive outcomes seen at the end of therapy may be 
due to the nonspecific treatment ingredients. However, it is the long-term gains in 
outcomes that can be attributed to specific treatment ingredients.   
 Several studies (Bush, Kanter, Landes, & Kohlenberg, 2006; Stiles et al., 2003; 
Tang & DeRubeis, 1999a, 1999b) looking at treatment outcomes across time found that 
the majority of the treatment gains occurred after the first session.  The comparative 
studies (Luborsky et al., 2002; Luborsky & Singer, 1975; Wampold et al., 1997) 
mentioned earlier concluded that there were no differences between different 
psychotherapies and that they all led to similar gains, which were attributed to the 
nonspecific factors rather than active ingredients. Finally, the results at treatment 
completion found in the present meta-analysis as well as the one conducted by Ahn and 
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Wampold (2001) also underscore nonspecific factors as paramount. However, there may 
be an alternative explanation in which specific active ingredients do lead to specific 
changes. First, nonspecific factors are likely responsible for the initial change seen in 
clients.  If treatment outcomes are only measured once at the end of psychotherapy (often 
a 6- to 12-week process), differences between psychotherapy ingredients or treatments 
may not be found because it is too early to detect any change beyond the benefits of 
nonspecific factors.  This possibility is supported by the present study’s findings which 
showed that the full packages were more beneficial at follow-up assessment. In other 
words, assessment of the initial outcomes may not have allowed enough time for the 
clients to demonstrate their benefit from the specific ingredients. Anecdotally, this pattern 
mirrors what therapists often describe with their clients in therapy. For example, 
cognitive therapists (e.g., Beck, 1995) often use techniques that aim to teach the client to 
become their own therapist; however, the process takes practice and the implementation 
of many tools over time. With time, the client should become better at being their own 
therapist and effectively using the specific techniques, which may be reflected in follow-
up assessments (i.e., as supported by the present study). As such, it may be unreasonable 
for researchers and practitioners to expect huge treatment successes in a short amount of 
time. A second possibility is that clients who only received dismantled component 
packages lost the benefits initially showed at outcomes over time.  It could be these less 
complete packages do not have the staying power and, therefore, the full package out 
performed the component package over time.  
 The current study contributes to the literature by answering an important question 
about the utility of component treatment studies.  Component treatment studies are able 
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to provide information on active ingredients, but the typical time of measurement (at the 
end of treatment) may not be as useful as previously thought. Although it is difficult to 
keep clients engaged in research over long time periods due to various challenges, the 
present study suggests that it is still important to attempt to obtain longer follow-up data.  
Neither component studies nor comparative studies may be able to provide useful 
information about particular components if treatment outcomes are limited solely to the 
end of treatment. Since clients generally benefit more from the full treatment package at 
follow-up, it may not be the best approach to offer only certain components.  
Additionally, it may be beneficial to contact clients after termination to collect follow-up 
data on their progress.  As addressed earlier in this paper, there has been an ongoing 
theoretical debate over the mechanisms of change in psychotherapy.  The present study 
provides evidence that both nonspecific factors (particularly during initial phases of 
therapy) and specific ingredients (particularly after time, which would allow practice of 
techniques) in therapy contribute to the change seen in treatment outcomes.   
Limitations and Future Directions 
 Although the present study provides important information about component 
designs and research outcomes, there are some limitations to consider. First, this meta-
analytic review was restricted by the small number of studies (k = 59) included in the 
analysis.  However, this review did include more studies than the Ahn and Wampold 
(2001) review (k = 20).  Additionally, the electronic literature search was limited by the 
useful search terms available.  The search terms originally proposed were too broad, 
captured more studies than manageable, and returned irrelevant studies.  
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 There are also limitations that are inherent to any meta-analytic review.  In a meta-
analysis, it is preferable to include studies similar enough to be combined.  Although all 
of the studies included were component studies, which was the research design of 
interest, the studies were diverse in treatment approach and treatment problem. Although 
the diversity of these studies should increase the external validity or generalizablity of the 
findings, it also limits the present study’s internal validity.  In addition to ranging in 
treatment problem and approach, the studies most likely differ in the quality of the 
research conducted.  It would have been beneficial to rank the studies on quality of 
research; however, doing so would risk introducing bias of the investigator and would not 
allow the literature to speak for itself.  Finally, author allegiance may not have been 
evenly balanced across the studies included.  For example, researchers who come from a 
certain theoretical perspective may interpret empirical results in a way that complements 
their own viewpoint.  Although author allegiance is a limitation to any meta-analysis, 
there is not a realistic way to code studies for author allegiance.       
 Given the findings of the present study, future component research should focus on 
providing long-term outcome assessments to examine whether evidence to support 
specific ingredients exist after a delay in time.  Comparative research studies may also 
find a difference between treatments with longer follow-up assessments.  The discussion 
over why psychotherapy works is far from resolved, but the present study provides some 
suggestions to move future research in the right direction. 
 In conclusion, the present meta-analysis indicates that there are no differences in 
treatment outcomes between a therapy component treatment and the full treatment 
package directly following treatment.  However, small but significant differences do exist 
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between components and full treatments at follow-up assessments.  These differences 
favor the full treatment package, indicating that specific ingredients in psychotherapy 
may be more effective than just nonspecific factors common to all therapy.  It should be 
clear from this review that future component studies should include long-term follow-up 
assessments.
   
 
 
 
 
   
Table A1  
 
General Information on Studies That Examined the Difference between a Full Treatment Package and the Component 
     More                             Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
Applebaum et al. (1990) Tension Headache CT+PMR (n=17)  PMR (n=16)  .246 
Barlow et al. (1989) Panic Disorder PMR+EX+CR (n= 16) PMR (n=10)  .379 
   PMR+EX+CR (n=16) EX+CR (n=15)  -.108 
       .136(average d) 
Barlow et al. (1992) GAD  CT+PMR (n=11)  PMR (n=10)  .300 
   CT+PMR (n=11)  CT (n=13)  .228 
       .264(average d) 
Baucom et al. (1990) Marital Discord CR+BMT (n=12)  BMT (n=12)  .449 
   EET+BMT (n=12) BMT (n=12)  -.202 
   EET+CR+BMT (n=12) BMT (n=12)  .485   
       -.200(average d) 
Bauman & MeInyk (1994) Test Anxiety EMDR (n=15)  FTDR (n=15)  .029 
Blanchard et al. (1990) Tension Headache CT+PMR (n=16)  PMR (n=19)  .127 
Borkovec et al. (2002) GAD  CT+SCD (n=23)  CT (n=23)  -.054 
   CT+SCD (n=23)  SCD (n=23)  -.276 
       -.165(average d) 
Borkovec & Costello (1993) GAD  CBT (n=18)  AR (n=18)  -.187 
Bryant et al. (2003) PTSD IE +CR (n=20)  IE (n=20)  -.247 
Bryant et al. (2005) Acute Stress  CBT+hypnosis (n=30) CBT (n=33)  -.037                                        
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Table A1 (continued). 
                                                                                                                                                                                                                             
     More                           Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
Bryant et al. (2008) PTSD IE+In Vivo EX+CT (n=28) IE (n=31)    -.832 
   IE+In Vivo EX+CT (n=28) In Vivo EX (n=28)         -1.009 
   IE+In Vivo EX+CT (n=28) IE+In Vivo EX (n=31)  -.775 
         -.872 (average d)  
Cusack & Spates (1999) PTSD EMDR (n=11)  EMD-R (n=11)    .004 
Dadds & McHugh (1992) Child Conduct  CMT+ Ally (n=11) CMT (n=11)    -.185 
De Jong et al. (2000) Spider phobia EX+CC (n=18)  EX (n=16)      .245 
de Zwaan et al. (2005) Binge eating BT (VLCD)+CBT (n=36) BT(VLCD) (n=35)     .173 
Deffenbacher et al. (2002) Angry drivers CRCS (n=17)  RCS (n=16)     -.349 
Deffenbacher & Stark (1992) General anger CRCS (n=16)  RCS (n=19)   .153 
Devilly et al. (1998) PTSD EMDR (n=12)  EMDR-EM (n=12)  -.326 
Dunn et al. (1996) Anxiety EMD (n=14)  No Eye Movement (n=14) -.001  
Emmelkamp & Beens (1991) OCD  EX+CT (n=10)  EX (n=11)   -.323 
Fesk & Goldstein (1997) Panic disorder EMDR (n=18)  EFER (n=18)   -.002 
Flessner et al. (2005) Nail biting SHR (n=18)  SHR-social support (n=20) -.144 
Foa et al. (2005) PTSD PE+CR (n=74)  PE (n=79)   -.079 
Foa & Rauch (2004) PTSD PE+CR (n=27)  PE (n=27)   -.218 
Foley & Spates (1995) Public speaking phobia EMD (n=10)  EX w/ resting eyes (n=10)     -.437   
   EMD (n=10)  EX w/movement to sound (n=10) .526 
         .045 (average d) 
Gosselin & Matthews (1995) Test anxiety EMD (n=21)  EMD-EM (n=20)  -.120 
Grunes et al. (2001) OCD  ERP+FI (n=14)  ERP (n=14)   -.424 
Halford et al. (1993) Marital Discord EBMT (n=13)  BMT (n=13)     .313 
Hope et al. (1995) Social phobia CBT (n=13)  Exposure only (n=10)    .253                                 
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Table A1 (continued). 
                                                                                                                                                                                                                            
     More                           Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
Jacobson et al. (1996) Depression BA+AT (n=49)  AT (n=42)   -.003  
   BA+AT (n=49)  BA (n=55)   .127 
        .062 (average d) 
Kazdin & Whitley (2003) Child Conduct PSST+PMT+PPS (n=57) PSST+PMT (n=70)  .323 
Koch et al. (2004)                 Small animal phobia CBT+EX (n=20) EX (n=20)                      -.484 
Marks et al. (1998) PTSD EX+CR (n=20)  EX (n=20)  .383    
   EX+CR (n=20)  CR (n=19)  .333 
       .358 (average d) 
Mattick et al. (1989) Social phobia CBT (n=11)  CR (n=11)  -.426  
  CBT(n=11)  EX (n=11)  -.216    
      -.321(average d) 
McKay et al. (2010) Cocaine dependence RP+CM (n=25)  CM (n=26)  .0 
Nezu & Perri (1989) Depression PST (n=14)  APST (n=14)  -1.295 
Nicholas et al. (1991) Chronic back pain BT+PMR (n=8)  BT (n=9)  .795 
Nicholas et al. (1991) Chronic back pain CT+PMR (n=8)  CT (n=7)  -1.567 
Öst et al. (2004) Panic disorder CBT (n=34)  EX (n=29)  .047 
Öst et al. (1991) Blood phobia ATP (n=10)  Tension only (n=10) -.356 
  ATP (n=10)  EX (n=10)  .149 
      -.104 (average d) 
Paunovic & Ost (2001) PTSD CBT+EX (n=7)  EX (n=9)  -.300 
Petry et al. (2008) Gambling problems MT+CBT (n=40) MT (n=55)  -.309 
Pitman et al. (1996) PTSD EMDR (n=16)  EMDR-EM (n=14) .232 
Porzelius et al. (1995) Eating disorder OBET (n=25)  CBT (n=21)  .068 
Propst et al. (1992) Depression CBT-Religious (n= 10) CBT (n=10)                     -.364                                
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Table A1 (continued). 
                                                                                                                                                                                                                          
     More                           Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
 
 
Radojevic et al. (1992) Rheumatoid arthritis BT+social support (n=15) BT (n=14)  -.224 
    BT+social support (n=15) Social support (n=15) -.121 
        -.180 (average d) 
Resick et al. (2008) PTSD CPT package (n=42) CPT-C (n=38)  .099 
    CPT package (n=42) Written Alone (n=38) -.348 
      -.125 (average d)  
Roehrig et al. (2006) Body image  CA+EX (n=30)  CA (n=36)  .339 
Rohan et al. (2007) SAD  CBT+Light Therapy(n=15) Light Therapy (n=16) .478 
   CBT+ Light Therapy (n=15) CBT (n=15)  .469 
       .473 (average d) 
Rosen et al. (1990) Body image CBTP (n=13)  CBT (n=11)  .183 
Sanders & McFarland (2000) Family behavior CBFI (n=23)  BFI (n=24)  .980 
Sanderson & Carpenter(1992)Phobias EMD (n=32)  EMD-EM (n=30) -.086 
Schmidt et al. (2000) Panic Disorder CBT+breathing retraining(n=32) CBT (n=21)  -.368 
Schmiege et al. (2009) HIV/STD risk GPI+GMET (n=163) GPI (n=154)  .242 
Taylor et al. (2003) PTSD EMDR (n=15)  EMDR-EM (n=15) .633 
Thackwray et al. (1993) Bulimia nervosa CBT (n=13)  BT (n=13)  .760 
Walters et al. (2009) Alcohol problems MI+FB (n=70)  FB (n=57)  .054 
   MI+FB (n=70)  MI (n= 59)  -.092 
       -.019(average d) 
Webster-Stratton (1994) Parenting effectiveness GDVM+ADVANCE (n=38) GDVM (n=39) -.122                                  
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Table A1 (continued). 
                                                                                                                                                                                                                          
     More                           Fewer       
       components    components    
 Study  Disorder    group (n)    group (n)     Effect d 
 
Williams & Falbo (1996) Panic Disorder CBT (n=11)  BT (n=10)  .093 
   CBT (n=11)  CT (n=13)  .050 
       .072 (average d) 
Note. Disorder: GAD = Generalized Anxiety Disorder, PTSD = Post Traumatic Stress Disorder, OCD = Obsessive-Compulsive Disorder, SAD = Seasonal Affective Disorder, HIV = Human 
Immunodeficiency Virus, STD = Sexually Transmitted Disease. Component Group: CT = Cognitive Therapy; PMR = Progressive Muscle relaxation; EX = Exposure Therapy; CR = Cognitive 
Restructuring; BMT = Behavioral Marital Therapy; EET = Emotional Expressiveness Training; EMDR = Eye Movement Desensitization Reprocessing; FTDR= Finger Tapping Desensitization 
Restructuring; SCD = Self-Control Desensitization; AR = Applied Relaxation; CBT = Cognitive-Behavioral Therapy; IE = Imaginal Exposure; EMD-R = Eye Movement Desensitization without 
Reprocessing; CMT = Child Management Training; CC = Counter Conditioning; BT = Behavior Therapy; VLCD = Very Low Calorie Diet; CRCS = Cognitive and Relaxation Coping Skills; RCS = 
Relaxation Coping Skills; EMD = Eye Movement Desensitization; EFER = Eye Fixation Exposure and Reprocessing; SHR = Simplified Habit Reversal; PE = Prolonged Exposure; ERP = Exposure and 
Response Prevention; FI = Family Involvement; EBMT= Enhanced Behavioral Marital Therapy; BA = Behavioral Activation; AT = Automatic Thoughts; PSST = Problem Solving Skills Training; PMT 
= Parent Management Training; PPS = Parent Problem Solving; RP = Response Prevention; CM = Contingency Management; PST = Problem Solving Therapy; APST = Abbreviated Problem Solving 
Therapy; ATP = Applied Tension Package; MT = Motivational Techniques; CPT = Cognitive Processing Therapy; CPT-C = Cognitive Processing Therapy without the written component; CA = 
Counter Attitudinal Therapy; CBTP = Cognitive-Behavioral Therapy with Perception Training; CBFI = Cognitive-Behavioral Family Intervention; BFI = Behavioral Family Intervention; GPI = Theory 
based sexual risk reduction intervention; GMET = Group Based Motivational Enhancement Therapy; MI = Motivational Interviewing; FB = Feed Back; GDVM= videotaped parent skills training 
program; ADVANCE = cognitive training social learning program. 
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Table B1    
 
Follow-Up Information on Studies That Examined the Difference between a Full Treatment Package and the Component 
 
     More                            Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
Barlow et al. (1989) Panic Disorder PMR+EX+CR (n= 16) PMR (n=10)  .189 
   PMR+EX+CR (n=16) EX+CR (n=15)  .567 
       .378 (average d) 
        
Baucom et al. (1990) Marital Discord CR+BMT (n=12)  BMT (n=12)  -.032 
   EET+BMT (n=12) BMT (n=12)  .043 
   EET+CR+BMT (n=12) BMT (n=12)  .026   
       .012 (average d) 
Borkovec et al. (2002) GAD  CT+SCD (n=23)  CT (n=22)  -.174 
   CT+SCD (n=23)  SCD (n=21)  -.359 
       -.267 (average d) 
Borkovec & Costello (1993) GAD  CBT (n=17)  AR (n=17)  -.077 
Bryant et al. (2003) PTSD IE +CR (n=20)  IE (n=20)  -.357 
Bryant et al. (2005) Acute Stress  CBT+hypnosis (n=23) CBT (n=24)  -.017 
Bryant et al. (2008) PTSD IE+In Vivo EX+CT (n=21) IE (n=21)  -.899 
   IE+In Vivo EX+CT (n=21) In Vivo EX (n=21) -.927 
   IE+In Vivo EX+CT (n=21) IE+In Vivo EX (n=21) -.732 
       -.853 (average d)  
Dadds & McHugh (1992) Child Conduct  CMT+ Ally (n=6) CMT (n=5)   -.173 
De Jong et al. (2000) Spider phobia EX+CC (n=12)  EX (n=12)  .237 
Deffenbacher et al. (2002) Angry drivers CRCS (n=17)  RCS (n=16)  -.025                             
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Table B2 (continued). 
                                                                                                                                                                                                                          
     More                           Fewer       
       components    components    
 Study  Disorder    group (n)    group (n)     Effect d 
Deffenbacher & Stark (1992) General anger CRCS (n=12)  RCS (n=14)   .240 
Devilly et al. (1998) PTSD EMDR (n=13)  EMDR-EM (n=12) -.334 
Emmelkamp & Beens (1991) OCD  EX+CT (n=10)  EX (n=11)  -1.151 
Fesk & Goldstein (1997) Panic disorder EMDR (n=14)  EFER (n=14)  -.075 
Foa et al. (2005) PTSD PE+CR (n=42)  PE (n=47)  -.055 
Foa & Rauch (2004) PTSD PE+CR (n=18)  PE (n=20)  -.102 
Grunes et al. (2001) OCD  ERP+FI (n=14)  ERP (n=14)  -.463 
Halford et al. (1993) Marital Discord EBMT (n=13)  BMT (n=13)  -.058 
Hope et al. (1995) Social phobia CBT (n=9)  Exposure only (n=8)  .285 
Jacobson et al. (1996) Depression BA+AT (n=47)  AT (n=39)  -.057  
   BA+AT (n=47)  BA (n=50)  .091 
       .017 (average d) 
Koch et al. (2004)                 Small animal phobia CBT+EX (n=20) EX (n=20)                -.736 
Marks et al. (1998) PTSD EX+CR (n=11)  EX (n=12)                 .497    
   EX+CR (n=11)  CR (n=12)                -.864 
                     -.183 (average d) 
Mattick et al. (1989) Social phobia CBT (n=10)  CR (n=9)                  .356  
  CBT(n=10)  EX (n=10)                  .046    
                     -.301(average d) 
McKay et al. (2010) Cocaine dependence RP+CM (n=23)  CM (n=24)                 -.546 
Nezu & Perri (1989) Depression PST (n=14)  APST (n=14)               -1.208 
Nicholas et al. (1991) Chronic back pain BT+PMR (n=6)  BT (n=4)                 -.467 
Nicholas et al. (1991) Chronic back pain CT+PMR (n=5)  CT (n=5)                -1.324 
Öst et al. (2004) Panic disorder CBT (n=34)  EX (n=29)                   .025                                
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Table B2 (continued). 
                                                                                                                                                                                                                           
     More                           Fewer       
       components    components    
 Study  Disorder    group (n)    group (n)     Effect d 
 
 
Öst et al. (1991) Blood phobia ATP (n=10)  Tension only (n=10) -.424 
  ATP (n=10)  EX (n=10)  -.061 
      -.104 (average d) 
Paunovic & Ost (2001) PTSD CBT+EX (n=7)  EX (n=9)  -.153 
Petry et al. (2008) Gambling problems MT+CBT (n=34) MT (n=48)  -.281 
Porzelius et al. (1995) Eating disorder OBET (n=20)  CBT (n=19)  -.075 
Propst et al. (1992) Depression CBT-Religious (n= 10) CBT (n=10)  -.193 
Radojevic et al. (1992) Rheumatoid arthritis BT+social support (n=15) BT (n=14)  -.065 
    BT+social support (n=15) Social support (n=15) -.283 
        -.174 (average d) 
 
 
Resick et al. (2008) PTSD CPT package (n=44) CPT-C (n=36)  .012 
    CPT package (n=44) Written Alone (n=39) -.173 
      -.161 (average d)  
Roehrig et al. (2006) Body image  CA+EX (n=22)  CA (n=28)  -.005 
Rohan et al. (2007) SAD  CBT+Light Therapy(n=13) Light Therapy (n=14) -.156 
   CBT+ Light Therapy (n=13) CBT (n=11)  -.192 
       -.173 (average d) 
Rosen et al. (1990) Body image CBTP (n=13)  CBT (n=11)  .180 
Sanders & McFarland (2000) Family behavior CBFI (n=19)  BFI (n=20)  .980 
Schmidt et al. (2000) Panic Disorder CBT+breathing retraining(n=32) CBT (n=21)  -.397 
Thackwray et al. (1993) Bulimia nervosa CBT (n=13)  BT (n=13)  -.257                         
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Table B2 (continued). 
                                                                                                                                                                                                                           
     More                           Fewer       
       components    components    
 Study Disorder    group (n)    group (n)     Effect d 
 
 
Walters et al. (2009) Alcohol problems MI+FB (n=67)  FB (n=54)  -.079 
   MI+FB (n=67)  MI (n= 59)  -.281 
       -.180(average d) 
Webster-Stratton (1994) Parenting effectiveness GDVM+ADVANCE (n=22) GDVM (n=24) -.138 
Williams & Falbo (1996) Panic Disorder CBT (n=11)  BT (n=10)    .148 
   CBT (n=11)  CT (n=13)    .163 
         .154 (average d) 
Note. Disorder: GAD = Generalized Anxiety Disorder, PTSD = Post Traumatic Stress Disorder, OCD = Obsessive-Compulsive Disorder, SAD = Seasonal Affective Disorder, HIV = Human 
Immunodeficiency Virus, STD = Sexually Transmitted Disease. Component Group: CT = Cognitive Therapy; PMR = Progressive Muscle relaxation; EX = Exposure Therapy; CR = Cognitive 
Restructuring; BMT = Behavioral Marital Therapy; EET = Emotional Expressiveness Training; EMDR = Eye Movement Desensitization Reprocessing; FTDR= Finger Tapping Desensitization 
Restructuring; SCD = Self-Control Desensitization; AR = Applied Relaxation; CBT = Cognitive-Behavioral Therapy; IE = Imaginal Exposure; EMD-R = Eye Movement Desensitization without 
Reprocessing; CMT = Child Management Training; CC = Counter Conditioning; BT = Behavior Therapy; VLCD = Very Low Calorie Diet; CRCS = Cognitive and Relaxation Coping Skills; RCS = 
Relaxation Coping Skills; EMD = Eye Movement Desensitization; EFER = Eye Fixation Exposure and Reprocessing; SHR = Simplified Habit Reversal; PE = Prolonged Exposure; ERP = Exposure and 
Response Prevention; FI = Family Involvement; EBMT= Enhanced Behavioral Marital Therapy; BA = Behavioral Activation; AT = Automatic Thoughts; PSST = Problem Solving Skills Training; PMT 
= Parent Management Training; PPS = Parent Problem Solving; RP = Response Prevention; CM = Contingency Management; PST = Problem Solving Therapy; APST = Abbreviated Problem Solving 
Therapy; ATP = Applied Tension Package; MT = Motivational Techniques; CPT = Cognitive Processing Therapy; CPT-C = Cognitive Processing Therapy without the written component; CA = 
Counter Attitudinal Therapy; CBTP = Cognitive-Behavioral Therapy with Perception Training; CBFI = Cognitive-Behavioral Family Intervention; BFI = Behavioral Family Intervention; GPI = Theory 
based sexual risk reduction intervention; GMET = Group Based Motivational Enhancement Therapy; MI = Motivational Interviewing; FB = Feed Back; GDVM= videotaped parent skills training 
program; ADVANCE = cognitive training social learning program.
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APPENDIX C 
 
CRITERIA FOR INCLUSION  
 
Ahn and Wampold set the following as the criteria for inclusion in their 2001 meta-
analysis: 
 
To be included in this meta-analysis, a study had to (a) involve a  
psychological treatment intended to be therapeutic for a particular disorder, 
problem, or complaint and (b) contain the necessary statistics to conduct 
the meta-analysis. To determine that a treatment was intended to be 
therapeutic, we used the criteria developed by Wampold et al. (1997); 
specifically, a treatment had to involve a therapist who had at least a 
master's degree and who met face to face with the client and developed a 
relationship with the client. Moreover, the treatment had to contain at least 
two of the following four elements: (a) The treatment was based on an 
established treatment that was cited, (b) a description of the treatment was 
contained in the article, (c) a manual was used to guide administration of 
the treatment, and (d) active ingredients of the treatment were identified 
and cited. Finally, the study's research design had to involve a comparison 
of one group with another group, and one of the following two conditions 
had to be satisfied: (a) One, two, or three ingredients of the treatment were 
removed, leaving a treatment that would be considered logically viable 
(i.e., coherent and credible), or (b) one, two, or three ingredients that were 
compatible with the whole treatment and were theoretically or empirically 
hypothesized to be active were added to the treatment, providing a "super 
treatment." A study was excluded when treatment A was compared with 
 treatment B, where B was a subset of A but both A and B were established 
treatments in their own rights. (p. 252-253) 
 
 
 
 
 
 
 
 
 
 
   
 
 
APPENDIX D 
 
CODING SHEET FROM META-ANALYSIS DATA COLLECTION 
 
Descriptive Information 
Reference (APA style): 
1.  Study Number  
2.  Type of Publication 
1 = journal 
2 = book chapter 
3 = other (specify) 
3.  Publication year:  
4.  Mean age of sample  
a. if subgroups M of each 
 
5. Type of Client:  
 1= Volunteer (like college students seeking extra credit) 
 2=Clinical (real client) 
5b. Age= 
 1=Adult 
 2=Adolescent 
 3=Child 
6.  Sex ratio of sample (% female, % male) 
a. if subgroups % of each 
7.  Problem Type 
1 = depression 
2 = anxiety (i.e., generalized anxiety disorder) 
            3 = grief 
            4 = aggression 
 5 = psychotic disorders (i.e. Schizophrenia, Schizoaffective Disorder, Psychotic 
Mood  Disorder) 
 6 = personality disorders/interpersonal problems (i.e., Borderline Personality 
treated with  DBT) 
 7= Substance Use  
 8=PTSD 
 9= Panic Disorder 
 10=Phobias 
 11=OCD 
 12=Bipolar Disorder 
 13=Eating Disorder 
 14=Somatoform and Factitious Disorders 
 15=Health Disorders (i.e., headaches, rheumatoid arthritis) 
 16=Marital Discord 
   
 17=Child behavior problems 
 18=Parent-training 
 19=enuresis 
 20=Mixed 
 21=Other 
8. Type of Study design: 
 1= Within subjects design 
 2=Between subjects design 
 3=both 
9. Treatment Location 
 1=residential/inpatient 
 2=outpatient 
  
10.  Region 
1 = American 
2 = European (note country/language) 
3 = Other (list) 
11.  Treatment Intervention: 
1=CBT 
2=Exposure 
3=IPT 
4=Psychodynamic 
5=Behavioral Therapy 
6-Cognitive Therapy 
7=DBT 
8=EMDR 
9=Marriage and Family Therapy 
10= Applied Relaxation or PMR 
11=Other 
 
12. Measures of Pathology/Distress:  
  
13.  Sample size: 
1a. total sample (Use entire sample and not treatment completers when available): 
2a. Is the this just treatment completers or entire sample? 
b. component sample size 
c. full treatment package sample size 
14. Assignment to treatments= 
 1= random 
 2= nonrandom 
15. Order of treatment components: 
1=Module 
2=Simultaneous administration 
 
15a= If module, are they presented in the same order? 
1=yes 
   
2=no 
 
16. Number of sessions:   
  
17. Length of sessions:  
  
 
 
18.Dismantling Design:  
a. More Component Group (example BT+CT-BT; EET+CR+BMT–BMT): 
b. Less Component Group: 
c. Component being tested: 
 
 
EFFECT SIZE DATA: Feel free to copy and paste tables and then indicate on the table 
the needed figure.  
19.  Type of data effect size is based on (provide the values including df).  
 
Mean of more component group= 
Mean of less component group= 
SD= 
 
 
 
 
Follow-up Data; 
Provide Follow-up data at one time point, and this time point should be the follow-up 
data that is closest to 6 months. If you have several time points past and it is not clear 
which one is closest to the 6 month (3 month collected and 9 month collected, used the 
later time point so 9 months in this example). 
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